← FDA Drug Approvals (Drugs@FDA)

BUDESONIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2023-11-29

Drug application

FDA Application #

ANDA216667

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUDESONIDE

Generic name

BUDESONIDE

Active ingredients

BUDESONIDE

Dosage form

SUSPENSION

Route

INHALATION

Marketing status

Prescription

Sponsor

EUGIA PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2023-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown